|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/047 | |
| A61K 31/075 | |||
| A61K 31/336 | |||
| A61K 45/06 | |||
| A61K 38/12 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Number of the document | 2872161 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13809749.8 |
| Date of filing the European patent application | 2013-06-24 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/047320 |
| Date | 2013-06-24 |
| (87) | Number | WO 2014/004376 |
| Date | 2014-01-03 |
| (30) | Number | Date | Country code |
| 201261664279 P | 2012-06-26 | US | |
| 201361824672 P | 2013-05-17 | US |
| (72) |
BROWN, Dennis M., US
BACHA, Jeffrey A., CA
GARNER, William J., US
|
| (73) |
Del Mar Pharmaceuticals,
Suite 720 999 West Broadway, Vancouver, British Columbia V5Z 1K5,
CA
|
| (54) | DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS |
| DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS |